Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

Clinical trial NCT07486206 · RECRUITING

Trial details

NCT number: NCT07486206
Sponsor: Hospital de Granollers
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Interstitial Lung Disease (ILD)Fibrotic Interstitial Lung Disease Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)

Start date: 2026-03-09
Primary completion: 2028-03-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.